W. Kern Et Al. , "Oral moxifloxacin versus ciprofloxacin plus Amoxicillin-Clavulanate in patients with febrile neutropenia, low risk - a prospective, double-blind, randomized, multicenter EORTC-infectious Diseases Group (IDG) trial," INFECTION , vol.37, pp.56-57, 2009
Kern, W. Et Al. 2009. Oral moxifloxacin versus ciprofloxacin plus Amoxicillin-Clavulanate in patients with febrile neutropenia, low risk - a prospective, double-blind, randomized, multicenter EORTC-infectious Diseases Group (IDG) trial. INFECTION , vol.37 , 56-57.
Kern, W., Marchetti, O., Drgona, L., Akan, H., Aoun, M., Akova, M., ... de Bock, R.(2009). Oral moxifloxacin versus ciprofloxacin plus Amoxicillin-Clavulanate in patients with febrile neutropenia, low risk - a prospective, double-blind, randomized, multicenter EORTC-infectious Diseases Group (IDG) trial. INFECTION , vol.37, 56-57.
Kern, W. Et Al. "Oral moxifloxacin versus ciprofloxacin plus Amoxicillin-Clavulanate in patients with febrile neutropenia, low risk - a prospective, double-blind, randomized, multicenter EORTC-infectious Diseases Group (IDG) trial," INFECTION , vol.37, 56-57, 2009
Kern, W. Et Al. "Oral moxifloxacin versus ciprofloxacin plus Amoxicillin-Clavulanate in patients with febrile neutropenia, low risk - a prospective, double-blind, randomized, multicenter EORTC-infectious Diseases Group (IDG) trial." INFECTION , vol.37, pp.56-57, 2009
Kern, W. Et Al. (2009) . "Oral moxifloxacin versus ciprofloxacin plus Amoxicillin-Clavulanate in patients with febrile neutropenia, low risk - a prospective, double-blind, randomized, multicenter EORTC-infectious Diseases Group (IDG) trial." INFECTION , vol.37, pp.56-57.
@article{article, author={W. Kern Et Al. }, title={Oral moxifloxacin versus ciprofloxacin plus Amoxicillin-Clavulanate in patients with febrile neutropenia, low risk - a prospective, double-blind, randomized, multicenter EORTC-infectious Diseases Group (IDG) trial}, journal={INFECTION}, year=2009, pages={56-57} }